Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
- Status
- COMPLETED
- Phase
- PHASE2
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )
- Status
- COMPLETED
- Phase
- PHASE3
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE3
Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)
- Status
- TERMINATED
- Phase
- PHASE3
IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
- Status
- TERMINATED
- Phase
- PHASE2
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
- Status
- TERMINATED
- Phase
- PHASE2
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3